TFG Asset Management’s Freeline Therapeutics Holdings FRLN Stock Holding History
Bought
Maintained
Sold
Other funds holding FRLN
TFG Asset Management's FRLN Position: Q4 2023 in Review
TFG Asset Management sold out of Freeline Therapeutics Holdings (FRLN) in Q4 2023, closing a stake of 266,666 shares — an estimated $1.15M sold.
TFG Asset Management first reported a position in FRLN in Q3 2020 and held it in 13 quarters. The position peaked at $13.7M in Q4 2020. 15 funds tracked by Wall St. Rank hold FRLN as of Q4 2023.
- TFG Asset Management reported no remaining Freeline Therapeutics Holdings position as of Q4 2023 after selling out during the quarter.
- TFG Asset Management sold 266,666 Freeline Therapeutics Holdings shares in Q4 2023, an estimated $1.15M.
- TFG Asset Management first reported a position in Freeline Therapeutics Holdings in Q3 2020 and held it in 13 quarters.
- TFG Asset Management's Freeline Therapeutics Holdings position peaked at $13.7M in Q4 2020.
- 15 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings as of Q4 2023.
Based on TFG Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.